Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00726_DB00745_nanopub.RAdmhRU4rnrKk-4FtAC3qwoCfi4kPcfqZPu5F8c6jtxQk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00726_DB00745 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB00745 label "DDI between Trimipramine and Modafinil - The strong CYP2C19 inhibitor, Modafinil, may decrease the metabolism and clearance of Trimipramine, a CYP2D6 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Modafinil is initiated, discontinued or dose changed. [drugbank_resource:DB00726_DB00745]" assertion.
- drugbank_resource:DB00726_DB00745 identifier "drugbank_resource:DB00726_DB00745" assertion.
- drugbank_resource:DB00726_DB00745 title "DDI between Trimipramine and Modafinil - The strong CYP2C19 inhibitor, Modafinil, may decrease the metabolism and clearance of Trimipramine, a CYP2D6 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Modafinil is initiated, discontinued or dose changed." assertion.
- drugbank:DB00745 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB00745 assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB00745 assertion.